These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3437513)

  • 1. [Treatment of childhood acute non-lymphocytic leukemia with the AVC regimen (adriamycin, vincristine and cytosine arabinoside)].
    Tonouchi T; Toyoda Y; Mimaya J
    Rinsho Ketsueki; 1987 Sep; 28(9):1528-32. PubMed ID: 3437513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy].
    Imashuku S; Nakajima T; Morimoto S; Hibi S; Todo S; Morioka Y; Sugimoto T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):527-30. PubMed ID: 3813580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effects of a combination of intermediate-dose cytosine arabinoside, adriamycin and vincristine in relapsed acute leukemia].
    Takahashi I; Yorimitsu S; Inagaki T; Sekito N; Hayashi N; Nishimura M; Aoyama S; Nakada H; Ohmoto E; Uchida K
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):485-9. PubMed ID: 3813576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
    Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of acute childhood leukemia. A new protocol 811 for the high risk group of acute lymphocytic leukemia (Phase III study)].
    Mimaya J; Fujimoto T; Hiyoshi Y; Yanai M; Komazawa M; Sekine I; Koizumi S; Nishikawa K; Higashi O; Utsumi J
    Rinsho Ketsueki; 1984 Aug; 25(8):1190-6. PubMed ID: 6392601
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of acute nonlymphoblastic leukemia in childhood: results of protocol ANLL-827 and ANLL-861 studies. Children's Cancer and Leukemia Study Group].
    Yanai M; Tsuji Y; Takeda T; Oka T; Yatabe M; Kikuta A; Kaneko Y; Sekine I; Matsushita T; Utsumi J
    Rinsho Ketsueki; 1987 Oct; 28(10):1754-62. PubMed ID: 3330737
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myelogenous leukemia in children. ANLL9205 study by Children's Cancer and Leukemia Study Group (CCLSG)].
    Mimaya J; Horikoshi Y; Shimizu H; Maeda H; Koizumi S; Kawakami K; Watanabe A; Utsumi J; Kikuta A; Oka T; Mugishima H; Kawamura N; Gushiken T; Ohta S; Yamamura Y; Ishida Y; Sekine I; Okada N; Fujimoto T
    Rinsho Ketsueki; 1997 Feb; 38(2):100-7. PubMed ID: 9059063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modified VAPA therapy in children with acute nonlymphocytic leukemia].
    Morohashi F; Aonuma K; Katoh M; Kobayashi T; Hanaoka Y; Tsuji K; Norose N; Kawai H; Nakahata T; Tsukada M
    Rinsho Ketsueki; 1986 Nov; 27(11):2101-6. PubMed ID: 3820627
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of relapsing or refractory cases of acute myelogenous leukemia].
    Kawano F; Tejima Y; Tajima H; Lee SY; Shiozaki A; Nakai R; Chyosa M; Sawada T; Maeda Y; Mizokuni T
    Rinsho Ketsueki; 1986 Mar; 27(3):315-20. PubMed ID: 3461178
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probable cures of adult acute leukemia using short term intensive investigational chemotherapy.
    Vaughan WP; Karp JE; Burke PJ
    Nebr Med J; 1984 Aug; 69(8):264-8. PubMed ID: 6483053
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment and prognosis after late relapse in childhood acute lymphoblastic leukemia].
    Ikuta K; Fujioka K; Takahashi H; Sumita H; Sekiguchi H; Hanzawa N; Kai S; Kajigaya Y; Funabiki T; Okuyama T
    Rinsho Ketsueki; 1993 Jun; 34(6):712-7. PubMed ID: 8366572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Esumi N; Todo S; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [VP 16-213 in the treatment of acute leukemia in childhood].
    Esumi N; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
    Rigacci L; Carrai V; Nassi L; Alterini R; Longo G; Bernardi F; Bosi A
    Cancer; 2005 Mar; 103(5):970-7. PubMed ID: 15666323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the treatment of lymphoblastic leukemia by the BFM program in children--a 5-year observation].
    Rokicka-Milewska R; Derulska D; Makowska K; Skwarska E; Lewicki Z
    Acta Haematol Pol; 1987; 18(1-2):1-8. PubMed ID: 3481150
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.